NCT06244771: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 293 planned
- Started
- 12 Feb 2024
- Primary completion
- Oct 2027
- Arms
- FMC-376
- Results
- None posted
- 6 Feb 2024: Trial registered
- 12 Feb 2024: Trial started